FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to peptides recovered from MYBL2, which induce CTL, to pharmaceutical compositions containing as active ingredients MYBL2 polypeptides or polynucleotides coding them which are intended for treating and/or preventing tumours and/or preventing the post-operative recurrences thereof.
EFFECT: invention refers to methods for inducing an antigen-presenting cell with high ability to CTL induction.
16 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
| UBE2T PEPTIDE AND VACCINES CONTAINING THE SAME | 2013 |
|
RU2663350C2 |
| TOPK PEPTIDES AND THEIR VACCINES | 2012 |
|
RU2633503C2 |
| FOXP3 PEPTIDE VACCINE | 2007 |
|
RU2473557C2 |
| IMP-3 OLIGOPEPTIDES AND VACCINES CONTAINING THEREOF | 2010 |
|
RU2550695C2 |
| MODIFIED MELK PEPTIDES AND VACCINES CONTAINING LATTER | 2011 |
|
RU2580035C2 |
| TEM8 PEPTIDES AND VACCINES CONTAINING THEM | 2008 |
|
RU2498993C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES | 2007 |
|
RU2469044C2 |
| KNTC2 PEPTIDES AND VACCINES CONTAINING THE SAME | 2014 |
|
RU2671395C2 |
| NEIL3 PEPTIDES AND VACCINES INCLUDING SAME | 2010 |
|
RU2600888C2 |
